GENERIC NAME OF THE MEDICINAL PRODUCT:

Vincristine Sulphate for Injection USP 1mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

Vincristine Sulphate for Injection USP 1mg
Each sterile lyophilized vial contains:
Vincristine Sulphate IP…….……1mg
Mannitol IP ………………………….100mg
Sodium Hydroxide IP…………….q.s.
Sulfuric Acid IP……………………..q.s.

THERAPEUTIC INDICATION:

Vincristine sulphate is used for the treatment of Leukaemias including acute lymphocytic leukaemia, chronic lymphocytic leukaemia, acute myelogenous leukaemia and blastic crisis of chronic myelogenous leukaemia.

DIRECTION OF USE:

For Intravenous infusion only.
Please refer accompanying package insert for detailed dosage, directions for use and precautions.

CAUTION & WARNING:

CAUTION: This injection should not be used if it contains visible particulate matter after reconstitution. Fatal if given Intrathecally, for Intravenous use only.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an Oncologist/ Cancer Hospital only.
Cytotoxic special handling procedures see insert
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.
Discard Unused portion.
Keep out of the reach of the children.

STORAGE & DOSAGE:

Storage: Store the vials in the original carton between 2°C to 8°C (36° F to 46° F). Protect from light.
Dosage: As directed by an Oncologist.

Vincristine Sulphate for Injection USP 1mg (Vratucan) Technical Specification:

Product Name:Vincristine Sulphate for Injection USP 1mg
Brand Name:Vratucan
Strength:1mg
Dosage Form:Lyophilized
Dry Powder for Injection
Packing:SINGLE USE VIAL
Route of Administration:For I.V. infusion only.
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Documents:COA, MOA, Stability Studies, GMP
Therapeutic use:Anti-Cancer
Indication: Vincristine sulphate is used for the treatment of Leukaemias including acute lymphocytic leukaemia, chronic lymphocytic leukaemia, acute myelogenous leukaemia and blastic crisis of chronic myelogenous leukaemia.
Storage:Store the vials in the original carton between 2°C to 8°C (36° F to 46° F). Protect from light.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Vincristine Sulphate for Injection USP 1mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Vincristine Sulphate for Injection USP 1mg
    Each sterile lyophilized vial contains:
    Vincristine Sulphate IP…….……1mg
    Mannitol IP ………………………….100mg
    Sodium Hydroxide IP…………….q.s.
    Sulfuric Acid IP……………………..q.s.

THERAPEUTIC INDICATION:

Vincristine sulphate is used for the treatment of Leukaemias including acute lymphocytic leukaemia, chronic lymphocytic leukaemia, acute myelogenous leukaemia and blastic crisis of chronic myelogenous leukaemia.

DIRECTION OF USE:

For Intravenous infusion only.

Please refer accompanying package insert for detailed dosage, directions for use and precautions.

CAUTION & WARNING:

CAUTION: This injection should not be used if it contains visible particulate matter after reconstitution. Fatal if given Intrathecally, for Intravenous use only.

WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an Oncologist/ Cancer Hospital only.

Cytotoxic special handling procedures see insert

FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.

Discard Unused portion.

Keep out of the reach of the children.

STORAGE & DOSAGE:

Storage: Store the vials in the original carton between 2°C to 8°C (36° F to 46° F). Protect from light.

Dosage: As directed by an Oncologist.